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1. INTRODUCTION {#ags312315-sec-0001}
===============

Minimally invasive esophagectomy (MIE) has been performed increasingly more frequently for the treatment of esophageal cancer, ever since it was first reported by Cuschieri et al in 1992.[1](#ags312315-bib-0001){ref-type="ref"} However, in contrast to the case for open transthoracic esophagectomy, the postoperative complications of MIE have not yet been well‐characterized, because: (a) there are few reports of studies with a sufficient sample size; (b) a variety of MIE techniques are used, such as McKeown esophagectomy (thoracoscopic esophagectomy with cervical anastomosis),[2](#ags312315-bib-0002){ref-type="ref"} Ivor Lewis esophagectomy (thoracoscopic esophagectomy with intrathoracic anastomosis),[3](#ags312315-bib-0003){ref-type="ref"} and transmediastinal esophagectomy (TME, mediastinoscopic esophagectomy with cervical anastomosis)[4](#ags312315-bib-0004){ref-type="ref"}; and (c) there are few reports in which an established system for classifying the severity of complications, such as the Clavien--Dindo classification,[5](#ags312315-bib-0005){ref-type="ref"} Common Terminology Criteria for Adverse Events (CTCAE),[6](#ags312315-bib-0006){ref-type="ref"} or Complications Definitions by the Esophageal Complications Consensus Group (ECCG) has been used.[7](#ags312315-bib-0007){ref-type="ref"}

According to an analysis of the data obtained from 24 high‐volume centers for esophageal surgery in 14 countries conducted by the ECCG with the objective of developing a standardized platform for recording complications and quality measures associated with esophagectomy, the most common individual complications were pneumonia (14.6%), arrhythmia (14.5%), anastomotic leakage (11.4%), conduit necrosis (1.3%), chylothorax (4.7%), and recurrent laryngeal nerve palsy (4.2%).[7](#ags312315-bib-0007){ref-type="ref"} Therefore, we decided to focus on these complications in this review.

In the initial decades in the history of MIE, the number of studies that included sufficient numbers of patients was too few to allow reliable analysis of the rates of complications. As the number of treated patients at each institution began to increase around the world, studies conducted on larger study samples began to be published. Herein, we present a review of studies that included a sample size of at least 50 cases each. There are no results of nationwide analyses of the complications of MIE depending on the MIE technique adopted. Moreover, robotic‐assisted esophagectomy has also begun to be performed and some informative data have been reported, so that all the available data need to be collated and analyzed comprehensively.

To the best of our knowledge, there are only a few reports on the postoperative complications of MIE for esophageal cancer analyzed according to the MIE technique employed. In this review, we analyze very recent evidence reported in respect to the complications of MIE.

2. STUDY SELECTION {#ags312315-sec-0002}
==================

An electronic search for articles was conducted of the Medline database and a manual search was conducted for references related to studies on MIE published until 8 September 2019. A total of 48 out of 1245 studies were selected (a) that included more than 50 patients each, (b) in which the MIE technique used was clearly described, and (c) in which the complications were adequately described.[8](#ags312315-bib-0008){ref-type="ref"}, [9](#ags312315-bib-0009){ref-type="ref"}, [10](#ags312315-bib-0010){ref-type="ref"}, [11](#ags312315-bib-0011){ref-type="ref"}, [12](#ags312315-bib-0012){ref-type="ref"}, [13](#ags312315-bib-0013){ref-type="ref"}, [14](#ags312315-bib-0014){ref-type="ref"}, [15](#ags312315-bib-0015){ref-type="ref"}, [16](#ags312315-bib-0016){ref-type="ref"}, [17](#ags312315-bib-0017){ref-type="ref"}, [18](#ags312315-bib-0018){ref-type="ref"}, [19](#ags312315-bib-0019){ref-type="ref"}, [20](#ags312315-bib-0020){ref-type="ref"}, [21](#ags312315-bib-0021){ref-type="ref"}, [22](#ags312315-bib-0022){ref-type="ref"}, [23](#ags312315-bib-0023){ref-type="ref"}, [24](#ags312315-bib-0024){ref-type="ref"}, [25](#ags312315-bib-0025){ref-type="ref"}, [26](#ags312315-bib-0026){ref-type="ref"}, [27](#ags312315-bib-0027){ref-type="ref"}, [28](#ags312315-bib-0028){ref-type="ref"}, [29](#ags312315-bib-0029){ref-type="ref"}, [30](#ags312315-bib-0030){ref-type="ref"}, [31](#ags312315-bib-0031){ref-type="ref"}, [32](#ags312315-bib-0032){ref-type="ref"}, [33](#ags312315-bib-0033){ref-type="ref"}, [34](#ags312315-bib-0034){ref-type="ref"}, [35](#ags312315-bib-0035){ref-type="ref"}, [36](#ags312315-bib-0036){ref-type="ref"}, [37](#ags312315-bib-0037){ref-type="ref"}, [38](#ags312315-bib-0038){ref-type="ref"}, [39](#ags312315-bib-0039){ref-type="ref"}, [40](#ags312315-bib-0040){ref-type="ref"}, [41](#ags312315-bib-0041){ref-type="ref"}, [42](#ags312315-bib-0042){ref-type="ref"}, [43](#ags312315-bib-0043){ref-type="ref"}, [44](#ags312315-bib-0044){ref-type="ref"}, [45](#ags312315-bib-0045){ref-type="ref"}, [46](#ags312315-bib-0046){ref-type="ref"}, [47](#ags312315-bib-0047){ref-type="ref"}, [48](#ags312315-bib-0048){ref-type="ref"}, [49](#ags312315-bib-0049){ref-type="ref"}, [50](#ags312315-bib-0050){ref-type="ref"}, [51](#ags312315-bib-0051){ref-type="ref"}, [52](#ags312315-bib-0052){ref-type="ref"}, [53](#ags312315-bib-0053){ref-type="ref"}, [54](#ags312315-bib-0054){ref-type="ref"}, [55](#ags312315-bib-0055){ref-type="ref"} Four articles contained descriptions of two different MIE techniques, and a final 52 reports of MIE techniques described in 48 articles were analyzed.

2.1. Technique of MIE and postoperative complications {#ags312315-sec-0003}
-----------------------------------------------------

The median incidence of pneumonia was 10.6% in the reports of McKeown MIE, 12.3% in the reports of Ivor Lewis MIE, 27.8% in the reports of robotic‐assisted McKeown MIE, 6.9% in the reports of robotic‐assisted Ivor Lewis MIE, 6.5% in the reports of TME, and 10.6% overall in the reports of MIE (Tables [1](#ags312315-tbl-0001){ref-type="table"} and [2](#ags312315-tbl-0002){ref-type="table"}). The median incidence of arrhythmia was 9.3% in the reports of McKeown MIE, 17.2% in the reports of Ivor Lewis MIE, 15.3% in the reports of robotic‐assisted McKeown MIE, 11.7% in the reports of robotic‐assisted Ivor Lewis MIE, 3.6% in the reports of TME, and 11.7% overall in the reports of MIE. The median incidence of anastomotic leakage was 7.8% in the reports of McKeown MIE, 10.0% in the reports of Ivor Lewis MIE, 18.5% in the reports of robotic‐assisted McKeown MIE, 6.0% in the reports of robotic‐assisted Ivor Lewis MIE, 9.8% in the reports of TME, and 9.3% overall in the reports of MIE. The median incidence of conduit necrosis ranged from 0% to 4.0%. The median incidence of chylothorax was 3.2% in the reports of McKeown MIE, 3.8% in the reports of Ivor Lewis MIE, 24.6% in the reports of robotic‐assisted McKeown MIE, 2.4% in the reports of robotic‐assisted Ivor Lewis MIE, 0.0% in the reports of TME, and 3.4% overall in the reports of MIE. The median incidence of recurrent laryngeal nerve palsy was 9.2% in the reports of McKeown MIE, 0.3% in the reports of Ivor Lewis MIE, 9.3% in the reports of robotic‐assisted McKeown MIE, 6.6% in the reports of robotic‐assisted Ivor Lewis MIE, 19.0% in the reports of TME, and 8.9% overall in the reports of MIE.

###### 

Postoperative complications of MIE

  No.   Authors         Year   Ref                                         Country       Technique   Extent of LND   N (cases)   Pathology (cases)   Definition of Complication   Complication (%)                                                  
  ----- --------------- ------ ------------------------------------------- ------------- ----------- --------------- ----------- ------------------- ---------------------------- ------------------ ---------- -------- ------ ------ ----- ------ ------
  1     Osugi           2003   [8](#ags312315-bib-0008){ref-type="ref"}    Japan         M           UML             77          77                  0                            0                             15.6     1.3    1.3          3.9    14.3
  2     Yamamoto        2005   [9](#ags312315-bib-0009){ref-type="ref"}    Japan         M           UML             112         109                 3                            0                             6.3             8      0.8   2.7    8.9
  3     Shiraishi       2006   [10](#ags312315-bib-0010){ref-type="ref"}   Japan         M           UML             78          73                                                                             20.5     2.6    11.5                33.3
  4     Palanivelu      2006   [11](#ags312315-bib-0011){ref-type="ref"}   India         M           UML             130         130                 0                            0                             1.5      5.4    2.3          0.8    1.5
  5     Parameswaran    2009   [12](#ags312315-bib-0012){ref-type="ref"}   UK            M           UML             50          5                   41                           4                             8        0      14     4     6      12
  6     Puntambekar     2010   [13](#ags312315-bib-0013){ref-type="ref"}   India         M           UML             112         100                 12                           0                             7.1             2.7                 3.6
  7     Gao             2011   [14](#ags312315-bib-0014){ref-type="ref"}   China         M           UML             96          90                  4                            2                             13.5            7.3          1.1    2.1
  8     Kinjo           2012   [15](#ags312315-bib-0015){ref-type="ref"}   Japan         M           UML             106         102                 3                            1                  CTCAE      16       9.4    10.4         0.9    19.8
  9     Shen            2012   [16](#ags312315-bib-0016){ref-type="ref"}   China         M           UML             76          73                  1                            2                             6.6      11.8   21.1   2.6   1.3    9.2
  10    Chen            2013   [17](#ags312315-bib-0017){ref-type="ref"}   China         M           UML             142         131                 11                           0                             9.2      2.8    6.3    0.7   2.8    5.6
  11    Kubo            2014   [18](#ags312315-bib-0018){ref-type="ref"}   Japan         M           UML             93                                                                                         8.6             6.4    2.1   8.6    34
  12    Meng            2014   [19](#ags312315-bib-0019){ref-type="ref"}   China         M           UML             94          87                  3                            4                             9.6      4.1    6.4          3.2    4.3
  13    Hsu             2014   [20](#ags312315-bib-0020){ref-type="ref"}   Taiwan        M           UML             66          100                 0                            0                             10.6            27.3         6.1     
  14    Nozaki          2015   [21](#ags312315-bib-0021){ref-type="ref"}   Japan         M           UML             101                             0                                               CTCAE      7.9             6.9                 14.9
  15    Li              2015   [22](#ags312315-bib-0022){ref-type="ref"}   China         M           UML             89          82                  2                            5                             7.9      7.9    21.3         1.1    20.2
  16    Tanaka          2015   [23](#ags312315-bib-0023){ref-type="ref"}   Japan         M           UML             59          59                  0                            0                  CTCAE      13.6     11.9   6.8          0      22
  17    Uchihara        2018   [24](#ags312315-bib-0024){ref-type="ref"}   Japan         M           UML             184                                                                             CTCAE      12                           2.2     
  18    Seesing         2018   [25](#ags312315-bib-0025){ref-type="ref"}   Netherlands   M           UML             121                                                                                        36.4     19.8   26.4         33.9   7.4
  19    Kanekiyo        2018   [26](#ags312315-bib-0026){ref-type="ref"}   Japan         M           UML             65          65                  0                            0                             16.9     9.2    10.8                23.1
  20    Koyanagi        2018   [27](#ags312315-bib-0027){ref-type="ref"}   Japan         M           UML             67          63                  4                            0                             7.5             7.5                 19.4
  21    Akiyama         2018   [28](#ags312315-bib-0028){ref-type="ref"}   Japan         M           UML             87          84                  2                            1                             11.5            0      0     0      18.4
  22    Koterazawa      2019   [29](#ags312315-bib-0029){ref-type="ref"}   Japan         M           UML             162                                                                             CD         14.8            17.9                19.8
  23    Yamashita       2019   [30](#ags312315-bib-0030){ref-type="ref"}   Japan         M           UML             104                                                                             CD         10.6            5.8          4.8    20.2
  24    Luketich        2003   [31](#ags312315-bib-0031){ref-type="ref"}   USA           M           ML              220                                                                                        7.7      11.7   11.7   3.2   3.2    3.6
  25    Smithers        2007   [32](#ags312315-bib-0032){ref-type="ref"}   Australia     M           ML              332         77                  237                                                        26,0.2   16.6   5.4    1.5   5.1    2.4
  26    Dolan           2013   [33](#ags312315-bib-0033){ref-type="ref"}   USA           M           ML              68                                                                                         25.6     32.9   9.8          2.4    7.3
  27    Hong            2013   [34](#ags312315-bib-0034){ref-type="ref"}   China         M           ML              55          0                   55                           0                             9.1      9.1    10.9         5.5    0
  28    Brown           2018   [35](#ags312315-bib-0035){ref-type="ref"}   USA           M           ML              61          10                  51                           0                  CD         36.1     36.1   6.6    1.6   3.3    1.6
  29    van Workum      2018   [36](#ags312315-bib-0036){ref-type="ref"}   Netherlands   M           ML              226         45                  169                          12                 CD         24.8     26.1   26.5         13.3   9
  30    Zhang           2019   [37](#ags312315-bib-0037){ref-type="ref"}   China         IL          UML             108         107                 0                            1                             9.3             5.6          2.8    6.5
  31    Zingg           2009   [38](#ags312315-bib-0038){ref-type="ref"}   Australia     IL          ML              56          10                  46                           0                             30.9            20           3.6     
  32    Noble           2013   [39](#ags312315-bib-0039){ref-type="ref"}   UK            IL          ML              53                                                                              CD         34       11.3   9.4          1.9     
  33    Xie             2014   [40](#ags312315-bib-0040){ref-type="ref"}   China         IL          ML              106         98                  7                            1                             4.7      2.8    4.7          3.8    3.8
  34    Tapias          2014   [41](#ags312315-bib-0041){ref-type="ref"}   USA           IL          ML              80          11                  68                           1                             6.3      13.8   0      0     3.8    0
  35    Sihag           2015   [42](#ags312315-bib-0042){ref-type="ref"}   USA           IL          ML              600                                                                                        12.8            13.8         4.3     
  36    Tapias          2016   [43](#ags312315-bib-0043){ref-type="ref"}   USA           IL          ML              56          10                  46                           0                             5.4      17.9   0            5.4    0
  37    van Workum      2018   [36](#ags312315-bib-0036){ref-type="ref"}   Netherlands   IL          ML              561         53                  498                          10                 CD         27.8     17.1   14.4         8.7    0.5
  38    Gambhir         2019   [44](#ags312315-bib-0044){ref-type="ref"}   USA           IL          ML              75                                                                                                         10.6                 
  39    Meredith        2019   [45](#ags312315-bib-0045){ref-type="ref"}   USA           IL          ML              95                                                                                         13.7     17.9   4.2                  
  40    Souche          2019   [46](#ags312315-bib-0046){ref-type="ref"}   France        IL          ML              58          13                  45                           0                  CD         10.3     17.2   31     0            0
  41    Tagkalos        2019   [47](#ags312315-bib-0047){ref-type="ref"}   Germany       IL          ML              50                                                                                         18              18                   
  42    Naffouje        2019   [48](#ags312315-bib-0048){ref-type="ref"}   USA           IL          ML              161         14                  146                          1                             11.8            13                   
  43    Lorimer         2019   [49](#ags312315-bib-0049){ref-type="ref"}   USA           IL          ML              200         23                  176                          1                             17       23     8.5                  
  44    van der Sluis   2015   [50](#ags312315-bib-0050){ref-type="ref"}   Netherlands   RM          UML             108         20                  78                           10                 CD         33.3     8.3    18.5         17.6   9.3
  45    Park            2018   [51](#ags312315-bib-0051){ref-type="ref"}   Korea         RM          UML             140         131                                                                            8.8             9.3    0            25
  46    van der Sluis   2019   [52](#ags312315-bib-0052){ref-type="ref"}   Netherlands   RM          UML             54          13                  41                           0                             27.8     22.2   24.1   1.9   31.5   9.3
  47    Zhang           2019   [37](#ags312315-bib-0037){ref-type="ref"}   China         RIL         UML             76          74                  0                            2                             6.6             9.2          1.3    6.6
  48    Meredith        2018   [53](#ags312315-bib-0053){ref-type="ref"}   USA           RIL         ML              147         14                  126                          7                  CD         6.8      11.6   2.7          3.4     
  49    Meredith        2019   [45](#ags312315-bib-0045){ref-type="ref"}   USA           RIL         ML              144                                                                                        6.9      11.8   2.8                  
  50    Tagkalos        2019   [47](#ags312315-bib-0047){ref-type="ref"}   Germany       RIL         ML              50                                                                                         12              12                   
  51    Wang            2015   [54](#ags312315-bib-0054){ref-type="ref"}   China         TME         UML             194         194                 0                            0                             6.2      3.6    4.6                 4.6
  52    Fujiwara        2017   [55](#ags312315-bib-0055){ref-type="ref"}   Japan         TME         UML             60          58                  2                            0                  CD, ECCG   6.7             15           0      33.3

Abbreviations: Adeno., adenocarcinoma; CD, Clavien--Dindo classification; cond.nec., conduit necrosis; CTCAE, Common Terminology Criteria for Adverse Events; ECCG, Complications Definitions by the Esophageal Complications Consensus Group; IL, Ivor Lewis; LND, lymph node dissection; M, McKeown; MIE, Minimally invasive esophagectomy; ML, middle and lower mediastinum; RIL, Robotic‐assisted Ivor Lewis; RLNP, recurrent laryngeal nerve palsy; RM, Robotic‐assisted McKeown; SCC, squamous cell carcinoma; TME, transmediastinal esophagectomy; UML, upper, middle, and lower mediastinum.

John Wiley & Sons, Ltd

###### 

Technique of MIE and postoperative complications

  Technique of MIE                                     Complication (%)                              
  ---------------------------------------------------- ------------------ ------ ------ ----- ------ ------
  M (n = 29[a](#ags312315-note-0003){ref-type="fn"})                                                 
  Max.                                                 36.4               36.1   27.3   4.0   33.9   34.0
  Median                                               10.6               9.3    7.8    1.6   3.2    9.2
  Min.                                                 1.5                0.0    0.0    0.0   0.0    0.0
  IL (n = 14)                                                                                        
  Max.                                                 34.0               23.0   31.0   0.0   8.7    6.5
  Median                                               12.8               17.2   10.0   0.0   3.8    0.3
  Min.                                                 4.7                2.8    0.0    0.0   1.9    0.0
  RM (n = 3)                                                                                         
  Max.                                                 33.3               22.2   24.1   1.9   31.5   25.0
  Median                                               27.8               15.3   18.5   1.0   24.6   9.3
  Min.                                                 8.8                8.3    9.3    0.0   17.6   9.3
  RIL (n = 4)                                                                                        
  Max.                                                 12.0               11.8   12.0         3.4    6.6
  Median                                               6.9                11.7   6.0          2.4    6.6
  Min.                                                 6.6                11.6   2.7          1.3    6.6
  TME (n = 2)                                                                                        
  Max.                                                 6.7                3.6    15.0         0.0    33.3
  Median                                               6.5                3.6    9.8          0.0    19.0
  Min.                                                 6.2                3.6    4.6          0.0    4.6
  Total (n = 52)                                                                                     
  Max.                                                 36.4               36.1   31.0   4.0   33.9   34.0
  Median                                               10.6               11.7   9.3    1.5   3.4    8.9
  Min.                                                 1.5                0.0    0.0    0.0   0.0    0.0

Abbreviations: cond.nec., conduit necrosis; IL, Ivor Lewis; M, McKeown; MIE, Minimally invasive esophagectomy; RIL, Robotic‐assisted Ivor Lewis; RLNP, recurrent laryngeal nerve palsy; RM, Robotic‐assisted McKeown; TME, transmediastinal esophagectomy.

Number of reports.

John Wiley & Sons, Ltd

2.2. Extent of lymph node dissection and postoperative complications {#ags312315-sec-0004}
--------------------------------------------------------------------

The median incidence of recurrent laryngeal nerve palsy was 13.2% in the patients who underwent lymph node dissection of the nodes in the upper, middle, and lower mediastinum, and 1.6% in the patients who underwent lymph node dissection of the nodes in the middle and lower mediastinum (Tables [1](#ags312315-tbl-0001){ref-type="table"} and [3](#ags312315-tbl-0003){ref-type="table"}).

###### 

Extent of lymph node dissection and postoperative complications

  Extent of LND                                          Complication (%)                              
  ------------------------------------------------------ ------------------ ------ ------ ----- ------ ------
  UML (n = 30[a](#ags312315-note-0005){ref-type="fn"})                                                 
  Max.                                                   36.4               22.2   27.3   4.0   33.9   34.0
  Median                                                 9.5                7.9    8.0    1.4   2.8    13.2
  Min.                                                   1.5                0.0    0.0    0.0   0.0    1.5
  ML (n = 22)                                                                                          
  Max.                                                   36.1               36.1   31.0   3.2   13.3   9.0
  Median                                                 12.4               16.9   10.2   1.5   3.8    1.6
  Min.                                                   4.7                2.8    0.0    0.0   1.9    0.0
  Total (n = 52)                                                                                       
  Max.                                                   36.4               36.1   31.0   4.0   33.9   34.0
  Median                                                 10.6               11.7   9.3    1.5   3.4    8.9
  Min.                                                   1.5                0.0    0.0    0.0   0.0    0.0

Abbreviations: cond.nec., conduit necrosis; LND, lymph node dissection; ML, middle and lower mediastinum; RLNP, recurrent laryngeal nerve palsy; UML, upper, middle, and lower mediastinum.

Number of reports.

John Wiley & Sons, Ltd

2.3. Technique of MIE and extent of lymph node dissection {#ags312315-sec-0005}
---------------------------------------------------------

Lymph node dissection of the nodes in the upper, middle, and lower mediastinum was adopted in 81% of reports of McKeown MIE or robotic‐assisted McKeown MIE, in 11% of reports of Ivor Lewis MIE or robotic‐assisted Ivor Lewis MIE, and in 100% of reports of TME (Tables [1](#ags312315-tbl-0001){ref-type="table"} and [4](#ags312315-tbl-0004){ref-type="table"}).

###### 

Technique of MIE and extent of lymph node dissection

  Technique of MIE   Extent of LND                                      Total      
  ------------------ -------------------------------------------------- ---------- -----------
  M/RM               26 (81%)[a](#ags312315-note-0007){ref-type="fn"}   6 (19%)    32 (100%)
  IL/RIL             2 (11%)                                            16 (89%)   18 (100%)
  TME                2 (100%)                                           0 (0%)     2 (100%)
  Total              30 (58%)                                           22 (42%)   52 (100%)

Abbreviations: IL, Ivor Lewis; LND, lymph node dissection; M, McKeown; MIE, Minimally invasive esophagectomy; ML, middle and lower mediastinum; RIL, Robotic‐assisted Ivor Lewis; RM, Robotic‐assisted McKeown; TME, transmediastinal esophagectomy; UML, upper, middle, and lower mediastinum.

Number of reports.

John Wiley & Sons, Ltd

2.4. Technique of MIE and dominant pathology {#ags312315-sec-0006}
--------------------------------------------

The percentage of reports with a higher number of cases of squamous cell carcinoma than the number of adenocarcinoma cases was 68% among the reports of McKeown MIE or robotic‐assisted McKeown MIE, 27% among the reports of Ivor Lewis MIE or robotic‐assisted Ivor Lewis MIE, and 100% among the reports of TME (Tables [1](#ags312315-tbl-0001){ref-type="table"} and [5](#ags312315-tbl-0005){ref-type="table"}).

###### 

Technique of MIE and dominant pathology

  Technique of MIE   Dominant pathology                                 Total      
  ------------------ -------------------------------------------------- ---------- -----------
  M/RM               15 (68%)[a](#ags312315-note-0009){ref-type="fn"}   7 (32%)    22 (100%)
  IL/RIL             3 (27%)                                            8 (73%)    11 (100%)
  TME                2 (100%)                                           0 (0%)     2 (100%)
  Total              20 (57%)                                           15 (43%)   35 (100%)

Abbreviations: Adeno., adenocarcinoma; IL, Ivor Lewis; M, McKeown; MIE, Minimally invasive esophagectomy; RIL, Robotic‐assisted Ivor Lewis; RM, Robotic‐assisted McKeown; SCC, squamous cell carcinoma; TME, transmediastinal esophagectomy.

Number of reports.

John Wiley & Sons, Ltd

2.5. Technique of MIE adopted in different countries {#ags312315-sec-0007}
----------------------------------------------------

Countries in which the rate of selection of McKeown MIE or robotic‐assisted McKeown MIE was more than 80% were India, Japan, Korea, Netherlands, and Taiwan. The largest number, that is, 13 out of 29 (45%), of reports of McKeown MIE was from Japan. The median incidences of pneumonia, arrhythmia, anastomotic leakage, conduit necrosis, chylothorax, and recurrent laryngeal nerve palsy were 12.0%, 9.2%, 7.2%, 0.8%, 2.5%, and 19.8%, respectively, in the reports of McKeown MIE in Japan. Countries in which the rate of adoption of Ivor Lewis MIE or robotic‐assisted Ivor Lewis MIE was more than 75% were France, Germany, and the USA (Tables [1](#ags312315-tbl-0001){ref-type="table"} and [6](#ags312315-tbl-0006){ref-type="table"}).

###### 

Technique of MIE adopted in different countries

  Country       Technique of MIE                                                       
  ------------- ------------------------------------------------- ---------- --------- -----------
  Australia     1 (50%)[a](#ags312315-note-0011){ref-type="fn"}   1 (50%)              2 (100%)
  China         6 (60%)                                           3 (30%)    1 (10%)   10 (100%)
  France                                                          1 (100%)             1 (100%)
  Germany                                                         2 (100%)             2 (100%)
  India         2 (100%)                                                               2 (100%)
  Japan         13 (93%)                                                     1 (7%)    14 (100%)
  Korea         1 (100%)                                                               1 (100%)
  Netherlands   4 (80%)                                           1 (20%)              5 (100%)
  Taiwan        1 (100%)                                                               1 (100%)
  UK            1 (50%)                                           1 (50%)              2 (100%)
  USA           3 (25%)                                           9 (75%)              12 (100%)
  Total         32 (62%)                                          18 (35%)   2 (4%)    52 (100%)

Abbreviations: IL, Ivor Lewis; M, McKeown; MIE, Minimally invasive esophagectomy; RIL, Robotic‐assisted Ivor Lewis; RM, Robotic‐assisted McKeown; TME, transmediastinal esophagectomy.

Number of reports.

John Wiley & Sons, Ltd

2.6. Definition of complications {#ags312315-sec-0008}
--------------------------------

The Clavien--Dindo classification, CTCAE, or Complications Definitions by the ECCG was used for classifying the severity of complications in 14 of the 52 (27%) reports (Table [1](#ags312315-tbl-0001){ref-type="table"}).

3. DISCUSSION {#ags312315-sec-0009}
=============

The median incidences of pneumonia in all reports, except for the reports of robotic‐assisted McKeown MIE, were less than the 14.6% indicated in the ECCG report. The incidence of pneumonia was higher in the reports of robotic‐assisted McKeown MIE; two out of the three articles written on reports of robotic‐assisted McKeown MIE were written by the same author,[50](#ags312315-bib-0050){ref-type="ref"}, [52](#ags312315-bib-0052){ref-type="ref"} and it is possible that the surgical technique used by these authors was related to the higher incidence of pneumonia. One of the three reports of robotic‐assisted McKeown MIE reported an incidence of 8.8%,[51](#ags312315-bib-0051){ref-type="ref"} which was within the average range. The median incidences of arrhythmia in all reports, except for the reports of Ivor Lewis MIE and robotic‐assisted McKeown MIE, were less than the 14.5% indicated in the ECCG report. The median incidences of anastomotic leakage in all reports, except for the reports of robotic‐assisted McKeown MIE, were less than the 11.4% indicated in the ECCG report. The incidence of anastomotic leakage was relatively high in two of the three reports of robotic‐assisted McKeown MIE,[50](#ags312315-bib-0050){ref-type="ref"}, [52](#ags312315-bib-0052){ref-type="ref"} and it is possible that this higher incidence was related to the handsewn anastomotic technique used by the authors. However, in the remaining one of the three articles,[51](#ags312315-bib-0051){ref-type="ref"} which described the use of the stapler technique for anastomosis, the reported incidence was only 9.3%, which was within the average range. The heterogeneous anastomotic techniques were used in all studies, and no robust data are currently available on the association of the anastomotic technique (for example, handsewn versus stapled or different types of anastomotic configuration) with differences in outcome.[36](#ags312315-bib-0036){ref-type="ref"} It is necessary to clarify whether anastomotic techniques affect outcome after MIE in the future. Data on the incidence of conduit necrosis was described in only 13 of the 52 reports (23%) and this complication appeared to be rare. The median incidences of chylothorax in all reports, except for the reports of robotic‐assisted McKeown MIE, was less than the 4.7% indicated in the ECCG report. Resection of the thoracic duct may increase the risk of this complication.[56](#ags312315-bib-0056){ref-type="ref"} The incidence of chylothorax was relatively high in two reports of robotic‐assisted McKeown MIE,[50](#ags312315-bib-0050){ref-type="ref"}, [52](#ags312315-bib-0052){ref-type="ref"} which could be attributable to resection of the thoracic duct described in both reports.

The median incidences of recurrent laryngeal nerve palsy in all reports, except for the reports of Ivor Lewis MIE, were more than the 4.2% indicated in the ECCG report. Dissection of the upper mediastinal lymph nodes, especially lymph nodes around the right and the left recurrent laryngeal nerves, are oncologically necessary for all patients with thoracic esophageal squamous cell carcinoma, irrespective of the location.[57](#ags312315-bib-0057){ref-type="ref"} In general, lymph node dissection of nodes in the upper, middle, and lower mediastinum is selected in McKeown MIE, and lymph node dissection of only nodes in the middle and lower mediastinum, that is, no dissection of lymph nodes around the recurrent laryngeal nerves, is selected in Ivor Lewis MIE. Therefore, in Ivor Lewis MIE, the recurrent laryngeal nerves were rarely injured, and the rate of recurrent laryngeal nerve palsy was very low. On the other hand, more extensive dissection of lymph nodes from the chest and neck is performed in McKeown MIE than in Ivor Lewis MIE, and when anastomosis was performed in McKeown MIE, the upper esophagus was pulled out from the thoracic inlet. These procedures could lead to injury of the recurrent laryngeal nerves. Actually, when the relationships between the extent of lymph node dissection and the incidences of postoperative complications were analyzed, recurrent laryngeal nerve palsy rarely occurred in the patients who underwent lymph node dissection of nodes in the middle and lower mediastinum than in the patients who underwent lymph node dissection of nodes in the upper, middle, and lower mediastinum (Table [3](#ags312315-tbl-0003){ref-type="table"}).

However, is it true that lymph node dissection of the nodes in the upper, middle and lower mediastinum is selected in all cases of McKeown MIE and that lymph node dissection of only nodes in the middle and lower mediastinum is selected in all cases of Ivor Lewis MIE? Surprisingly, lymph node dissection of only nodes in the middle and lower mediastinum was reported in 19% of reports of McKeown MIE or robotic‐assisted McKeown MIE. On the other hand, lymph node dissection of nodes in the upper, middle, and lower mediastinum was reported in 11% of reports of Ivor Lewis MIE or robotic‐assisted Ivor Lewis MIE (Table [4](#ags312315-tbl-0004){ref-type="table"}). For example, Zhang et al adopted robotic‐assisted Ivor Lewis MIE with lymph node dissection of nodes in the upper, middle, and lower mediastinum, and reported a recurrent laryngeal nerve palsy rate of 6.6%.[37](#ags312315-bib-0037){ref-type="ref"} Therefore, we would like to mention that the MIE technique adopted does not always automatically reflect the extent of lymph node dissection. Attention must be paid not only to the MIE technique but also to the extent of lymph node dissection when analyzing the postoperative complications of MIE, especially recurrent laryngeal nerve palsy. Van Workum et al performed propensity score‐matched analysis to compare minimally invasive Ivor Lewis versus minimally invasive McKeown esophagectomy.[36](#ags312315-bib-0036){ref-type="ref"} They concluded that Ivor Lewis MIE was associated with a lower incidence of anastomotic leakage, 90‐day mortality and other postoperative morbidities as compared to McKeown MIE in patients in whom both procedures were oncologically feasible. This is very important information relevant to only patients with tumors in the distal esophagus and gastroesophageal junction. The complication rates in patients with tumors in other locations may not be similar to the rates in patients with tumors in the distal esophagus and gastroesophageal junction.

The pathology of esophageal cancer may be one of the factors guiding selection of the MIE technique to be adopted. The percentage of reports in which the number of cases of squamous cell carcinoma was more than the number of adenocarcinoma cases was 68% among the reports of McKeown MIE or robotic‐assisted McKeown MIE. On the other hand, the percentage of reports in which the number of cases of adenocarcinoma was more than the number of squamous cell carcinoma cases was 73% among the reports of Ivor Lewis MIE or robotic‐assisted Ivor Lewis MIE. Squamous cell carcinoma arises from stratified squamous epithelium anywhere in the esophagus, and the most frequent location is the middle esophagus.[58](#ags312315-bib-0058){ref-type="ref"}, [59](#ags312315-bib-0059){ref-type="ref"} Institutions where patients with squamous cell carcinoma were predominant may have tended to select McKeown MIE, robotic‐assisted McKeown MIE, or TME so as to accomplish adequate esophageal resection and lymph node dissection. Adenocarcinoma arises mainly from Barrett\'s epithelium and the most frequent location is the lower esophagus or the esophagogastric junction.[59](#ags312315-bib-0059){ref-type="ref"} Institutions where patients with adenocarcinoma were predominant may have tended to select Ivor Lewis MIE or robotic‐assisted Ivor Lewis MIE in order to accomplish adequate esophageal resection and lymph node dissection.

As for the MIE technique adopted in different countries, Asian countries and the Netherlands tended to adopt McKeown MIE, robotic‐assisted McKeown MIE, or TME. Japan published the largest number of reports of McKeown MIE. The median incidences of complications, except for the rates of recurrent laryngeal nerve palsy, were within average range. The reason why the rate of recurrent laryngeal nerve palsy was high may be due to the nationwide consensus on the need for intensive lymph node dissection of nodes in the upper, middle, and lower mediastinum, especially of those around the bilateral recurrent laryngeal nerves.[57](#ags312315-bib-0057){ref-type="ref"} Western countries, except the Netherlands, tended to adopt Ivor Lewis MIE or robotic‐assisted Ivor Lewis MIE. This may be due to epidemiological and pathological reasons: squamous cell carcinoma patients are more frequent in Asian countries, while adenocarcinoma patients are more frequent in western countries.

The severities of the complications were described in only 27% of the reports. The Clavien--Dindo classification, CTCAE, and Complications Definitions by the ECCG are available. For high‐quality analysis of postoperative complications, it would be desirable for surgeons to use officially approved classifications of the severities of complications.

4. CONCLUSION {#ags312315-sec-0010}
=============

The overall incidences of postoperative complications of MIE for esophageal cancer according to the MIE technique adopted, namely, McKeown MIE, Ivor Lewis MIE, robotic‐assisted McKeown MIE, robotic‐assisted Ivor Lewis MIE or TME, were analyzed. Pneumonia, arrhythmia, anastomotic leakage, and recurrent laryngeal nerve palsy occurred in about 10% of the patients each; Ivor Lewis MIE was associated with a relatively low incidence of recurrent laryngeal nerve palsy. It is important to recognize that the incidences of complications are influenced by the MIE technique adopted and the extent of lymph node dissection.
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